Sepsis Diagnostics Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2017 to 2026

Published on : Jan-2018 | List of Tables : 128 | List of Figures : 102 | No. of Pages : 170 | Report Code : FACT391MR | Format : ppt pdf Excel Word

Sepsis is emerging as one of the leading causes of mortality around the globe. However, early detection can improve the outcomes, hence the demand for sepsis diagnostics is also rising. Major companies in the market are also focusing on introducing technically advanced tools and techniques to provide sepsis diagnosis at an early stage. Companies are also entering into mergers and acquisitions to carry research and development activity and expand globally. New products are also being launched, while some products have already received the U.S. Food and Drugs Administration (FDA) clearance to be used for diagnosis purpose.

global sepsis diagnostics market

According to the new research by Fact.MR, the global market for sepsis diagnostics is likely to grow at a faster phase between 2017 and 2026. The global market for sepsis diagnostics is also projected to bring in US$ 707.3 million revenue by 2026 end.  

Market Taxonomy

Product Type

Method

Pathogen

Technology

Blood Culture Media

Conventional Diagnostics

Gram-negative Bacterial Sepsis

Microbiology

Instrument

Automated Diagnostics

Gram-positive Bacterial Sepsis

Molecular Diagnostics

Assays & Reagents

 

Fungal Sepsis

Immunoassays

   

Other Pathogens

Other Technology

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

For more insights, request sample of this report.

Assays & Reagents to Emerge as the Top-Selling Product

Among various products in sepsis diagnostics market, assays & reagents are likely to emerge as the top-selling products. Assays & reagents are projected to surpass US$ 300 million revenue by end of the forecast period. Reagents and assays kits are showing lucrative growth due to the introduction of technically advanced tests by key players. Moreover, assays and reagents facilitate early diagnosis of sepsis.

Conventional Diagnostics to be the Most-Preferred diagnostic Method

Compared to the automated diagnostics, conventional diagnostics is likely to emerge as the most-preferred sepsis diagnosis method. Towards 2026 end, conventional diagnostics is projected to generate more than US$ 400 million revenue. Conventional methods for diagnosis of sepsis is still the most-preferred one due to the low cost and it also leads to the timely changes to appropriate therapy.

Gram-positive Bacterial Sepsis to Hold the Largest Share on Basis of Pathogens Causing Septicemia

Gram-positive bacterial sepsis segment is likely to account for the maximum share in terms of revenue in the global market for sepsis diagnostics. Gram-positive bacterial sepsis are projected to reach close to US$ 300 million revenue by 2026 end. Although bacteria causes sepsis on a large scale, the increase in sepsis is due to the gram-positive sepsis. Various studies carried on sepsis are showing that gram-positive bacteria accounts for maximum septic shock and severe sepsis cases. Moreover, the mortality rate due to gram-positive infection is high as compared to the gram-negative infection. Hence, therapeutic protocols are being undertaken to manage both gram-positive and gram-negative sepsis.

Microbiology Technology to Witness Attractive Growth between 2017 and 2026

Compared to the various technologies, microbiology is likely to show attractive growth between 2017 and 2026. Microbiology technology is projected to reach nearly US$ 300 million revenue by 2026 end. It helps in identifying microorganisms for sepsis diagnosis and quantitative detection through culture media tests. Meanwhile, molecular diagnostics is also gaining traction in the market. Factors contributing to the growth of molecular diagnostics are accurate results and low turnaround time.

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global sepsis diagnostics market through 2026, which include Abionic SA, Biomérieux SA, Siemens Healthineers, Thermo Fisher Scientific Inc., Quidel Corporation, Becton, Dickinson and Company, Luminex Corporation, Abbott Laboratories, Inc., Qiagen NV, T2 Biosystems, Inc., Roche Holdings AG (Roche Diagnostics Limited), and Danaher Corporation (Beckman Coulter, Inc.).

Request research methodology of this report.

NoteThe insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

Sepsis is a body’s reaction to infection, it may develop from any type of infection. Increasing prevalence of sepsis is leading to an increasing need for early diagnosis. Hence, the demand for related diagnostic products is also anticipated to increase. In response to the increasing demand and need, the manufacturers of diagnostic products are also investing in the research and development of new products. This Fact.MR report analyzes the expansion of global sepsis diagnostics market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026.

Scope

The scope of Fact.MR’s report is to analyze the global sepsis diagnostics market for the forecast period 2017-2026 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global sepsis diagnostics market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to sepsis diagnostics.

Summary

The report commences with a brief information of the global sepsis diagnostics market. This executive summary sets the tone for the rest of the report, providing users the scope of the report. The executive summary includes important facts and statistics on the global sepsis diagnostics market.

Overview

The next section offers an overview of the global sepsis diagnostics market. This comprises an introduction to the market, along with a standard definition of the product – sepsis diagnostics. In this section, market value and year-over-year growth is offered to the readers. Year-over-year growth provides readers with a broader view of growth patterns over the forecast period.

The report’s succeeding section focuses on drivers, restraints and key trends from macroeconomic, demand, and supply perspectives. Impact analysis of weighted average model-based growth drivers is contained in the report for better provision of decision-making insights to clients.

In order to offer readers with up-to-date information about the latest advancements in the global sepsis diagnostics market, the report provides updates about market opportunities, which can benefit leading manufacturers of sepsis diagnostics. With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for sepsis diagnostics manufacturers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure are provided in this section.

Considering the broad scope of the global sepsis diagnostics market, the report by Fact.MR provides key insights and segmentation analysis and forecast. The global sepsis diagnostics market is segmented into product type, method, pathogen, technology, and region. The segment-wise analysis also provides detailed country-wise forecast by taking into account all the key parameters of the global sepsis diagnostics market.

The report’s last section comprises of the global sepsis diagnostics market competitive landscape, to provide readers with the dashboard view of company analysis and market players. This competitive intelligence is based on the providers’ categories across value chain, and their presence in the global sepsis diagnostics market.

Research Methodology

Fact.MR is committed to offer unbiased and independent market research solutions to its clients. Each market report of Fact.MR is compiled after months of exhaustive research. We bank on a mix of tried-and-tested and innovative research methodologies to offer the most comprehensive and accurate information. Our main sources of research include,

  • Primary research
  • Secondary research
  • Trade research
  • Focused interviews
  • Social media analysis

1. Global Economic Outlook

2. Global Sepsis Diagnostics Market - Executive Summary

3. Global Sepsis Diagnostics Market Overview
3.1. Introduction
       3.1.1. Global Sepsis Diagnostics Market Taxonomy
       3.1.2. Global Sepsis Diagnostics Market Definition
3.2. Global Sepsis Diagnostics Market Size (US$ Mn) and Forecast, 2012-2026
       3.2.1. Global Sepsis Diagnostics Market Y-o-Y Growth
3.3. Global Sepsis Diagnostics Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. New Technologies 
3.7. Sepsis types and mortality rates
3.8. Application of Sepsis Biomarkers
3.9. Early antimicrobial therapy in Septic Shock treatment
3.10. Commercially available systems and assays used for Sepsis diagnostics
3.11. Sepsis Epidemiology
3.12. Death rate of Sepsis as compared to other diseases
3.13. Surviving Sepsis Campaign
       3.13.1. Surviving Sepsis Campaign Guideline Process
3.14. PESTL Analysis
3.15. Product Lifecycle
3.16. Patent Analysis
3.17. Service Provider List
3.18. Key Participants Market Presence (Intensity Map) By Region

4. Global Sepsis Diagnostics Market Analysis and Forecast 2012-2026 
4.1. Global Sepsis Diagnostics Market Size and Forecast By Product Type, 2012-2026
       4.1.1. Blood Culture Media Market Size and Forecast, 2012-2026
                4.1.1.1. Revenue (US$ Mn) Comparison, By Region
                4.1.1.2. Market Share Comparison, By Region
                4.1.1.3. Y-o-Y growth Comparison, By Region
       4.1.2. Instrument Market Size and Forecast, 2012-2026
                4.1.2.1. Revenue (US$ Mn) Comparison, By Region
                4.1.2.2. Market Share Comparison, By Region
                4.1.2.3. Y-o-Y growth Comparison, By Region
       4.1.3. Assays & Reagents Market Size and Forecast, 2012-2026
                4.1.3.1. Revenue (US$ Mn) Comparison, By Region
                4.1.3.2. Market Share Comparison, By Region
                4.1.3.3. Y-o-Y growth Comparison, By Region
4.2. Global Sepsis Diagnostics Market Size and Forecast By Method, 2012-2026
       4.2.1. Conventional Diagnostics Market Size and Forecast, 2012-2026
                4.2.1.1. Revenue (US$ Mn) Comparison, By Region
                4.2.1.2. Market Share Comparison, By Region
                4.2.1.3. Y-o-Y growth Comparison, By Region
       4.2.2. Automated Diagnostics Market Size and Forecast, 2012-2026
                4.2.2.1. Revenue (US$ Mn) Comparison, By Region
                4.2.2.2. Market Share Comparison, By Region
                4.2.2.3. Y-o-Y growth Comparison, By Region
4.3. Global Sepsis Diagnostics Market Size and Forecast By Pathogen, 2012-2026
       4.3.1. Gram-negative Bacterial Sepsis Market Size and Forecast, 2012-2026
                4.3.1.1. Revenue (US$ Mn) Comparison, By Region
                4.3.1.2. Market Share Comparison, By Region
                4.3.1.3. Y-o-Y growth Comparison, By Region
       4.3.2. Gram-positive Bacterial Sepsis Market Size and Forecast, 2012-2026
                4.3.2.1. Revenue (US$ Mn) Comparison, By Region
                4.3.2.2. Market Share Comparison, By Region
                4.3.2.3. Y-o-Y growth Comparison, By Region
       4.3.3. Fungal Sepsis Market Size and Forecast, 2012-2026
                4.3.3.1. Revenue (US$ Mn) Comparison, By Region
                4.3.3.2. Market Share Comparison, By Region
                4.3.3.3. Y-o-Y growth Comparison, By Region
       4.3.4. Other Pathogens Market Size and Forecast, 2012-2026
                4.3.4.1. Revenue (US$ Mn) Comparison, By Region
                4.3.4.2. Market Share Comparison, By Region
                4.3.4.3. Y-o-Y growth Comparison, By Region
4.4. Global Sepsis Diagnostics Market Size and Forecast By Technology, 2012-2026
       4.4.1. Microbiology Market Size and Forecast, 2012-2026
                4.4.1.1. Revenue (US$ Mn) Comparison, By Region
                4.4.1.2. Market Share Comparison, By Region
                4.4.1.3. Y-o-Y growth Comparison, By Region
       4.4.2. Molecular Diagnostics Market Size and Forecast, 2012-2026
                4.4.2.1. Revenue (US$ Mn) Comparison, By Region
                4.4.2.2. Market Share Comparison, By Region
                4.4.2.3. Y-o-Y growth Comparison, By Region
       4.4.4. Flow Cytometry Market Size and Forecast, 2012-2026
                4.4.4.1. Revenue (US$ Mn) Comparison, By Region
                4.4.4.2. Market Share Comparison, By Region
                4.4.4.3. Y-o-Y growth Comparison, By Region
       4.4.4. Flow Cytometry Market Size and Forecast, 2012-2026
                4.4.4.1. Revenue (US$ Mn) Comparison, By Region
                4.4.4.2. Market Share Comparison, By Region
                4.4.4.3. Y-o-Y growth Comparison, By Region

5. North America Sepsis Diagnostics Market Size and Forecast, 2012-2026
5.1. North America Outlook 
5.2. North America Parent Market Outlook 
5.3. North America Target Market Outlook 
5.4. Revenue (US$ Mn) Comparison, By Country 
       5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
       5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
5.5. Revenue (US$ Mn) Comparison, By Product Type 
5.6. Revenue (US$ Mn) Comparison, By Method 
5.7. Revenue (US$ Mn) Comparison, By Pathogen 
5.8. Revenue (US$ Mn) Comparison, By Technology 

6. Latin America Sepsis Diagnostics Market Size and Forecast, 2012-2026
6.1. Latin America Outlook 
6.2. Latin America Parent Market Outlook 
6.3. Latin America Target Market Outlook 
6.4. Revenue (US$ Mn) Comparison, By Country 
       6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
       6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
       6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
6.5. Revenue (US$ Mn) Comparison, By Product Type 
6.6. Revenue (US$ Mn) Comparison, By Method 
6.7. Revenue (US$ Mn) Comparison, By Pathogen 
6.8. Revenue (US$ Mn) Comparison, By Technology 

7. Europe Sepsis Diagnostics Market Size and Forecast, 2012-2026
7.1. Europe Outlook 
7.2. Europe Parent Market Outlook 
7.3. Europe Target Market Outlook 
7.4. Revenue (US$ Mn) Comparison, By Country 
       7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
       7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
       7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
       7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
       7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
       7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
7.5. Revenue (US$ Mn) Comparison, By Product Type 
7.6. Revenue (US$ Mn) Comparison, By Method 
7.7. Revenue (US$ Mn) Comparison, By Pathogen 
7.8. Revenue (US$ Mn) Comparison, By Technology 

8. Japan Sepsis Diagnostics Market Size and Forecast, 2012-2026
8.1. Japan Outlook 
8.2. Japan Parent Market Outlook 
8.3. Japan Target Market Outlook 
8.4. Revenue (US$ Mn) Comparison, By Country 
       8.4.1. Japan Market Size and Forecast (US$ Mn), 2012-2026
8.5. Revenue (US$ Mn) Comparison, By Product Type 
8.6. Revenue (US$ Mn) Comparison, By Method 
8.7. Revenue (US$ Mn) Comparison, By Pathogen 
8.8. Revenue (US$ Mn) Comparison, By Technology 

9. APEJ Sepsis Diagnostics Market Size and Forecast, 2012-2026
9.1. APEJ Outlook 
9.2. APEJ Parent Market Outlook 
9.3. APEJ Target Market Outlook 
9.4. Revenue (US$ Mn) Comparison, By Country 
       9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
       9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
       9.4.3. Thailand Market Size and Forecast (US$ Mn), 2012-2026
       9.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026
       9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026
       9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
9.5. Revenue (US$ Mn) Comparison, By Product Type 
9.6. Revenue (US$ Mn) Comparison, By Method 
9.7. Revenue (US$ Mn) Comparison, By Pathogen 
9.8. Revenue (US$ Mn) Comparison, By Technology 

10. MEA Sepsis Diagnostics Market Size and Forecast, 2012-2026
10.1. MEA Outlook 
10.2. MEA Parent Market Outlook 
10.3. MEA Target Market Outlook 
10.4. Revenue (US$ Mn) Comparison, By Country 
       10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
       10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
       10.4.3. Israel Market Size and Forecast (US$ Mn), 2012-2026
       10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
10.5. Revenue (US$ Mn) Comparison, By Product Type 
10.6. Revenue (US$ Mn) Comparison, By Method 
10.7. Revenue (US$ Mn) Comparison, By Pathogen 
10.8. Revenue (US$ Mn) Comparison, By Technology 

11. Global Sepsis Diagnostics Market Company Share, Competition Landscape and Company Profiles
11.1. Company Share Analysis
11.2. Competition Landscape
11.3. Company Profiles
       11.3.1. Biomérieux SA 
       11.3.2. Becton, Dickinson and Company 
       11.3.3. Thermo Fisher Scientific Inc. 
       11.3.4. Abbott Laboratories, Inc. 
       11.3.5. Roche Holdings AG (Roche Diagnostics Limited)
       11.3.6. T2 Biosystems, Inc. 
       11.3.7. Danaher Corporation (Beckman Coulter, Inc.)
       11.3.8. Luminex Corporation 
       11.3.9. Qiagen NV
       11.3.10. Siemens Healthineers
       11.3.11. Quidel Corporation 
       11.3.12. Abionic SA
       11.3.13. OpGen, Inc.
       11.3.14. Curetis N.V.
       11.3.15. CytoSorbents Corporation
       11.3.16. Fujirebio Europe NV
       11.3.17. Hansa Medical AB
       11.3.18. Hain Lifescience GmbH
       11.3.19. Immunexpress Pty Ltd
       11.3.20.Inflammatix, Inc.
       11.3.21.Miacom diagnostics GmbH
       11.3.22.Nanomix, Inc.
       11.3.23.Radiometer Medical Aps
       11.3.24.Response Biomedical Corp.
       11.3.25.Sekisui Diagnostics LLC

12. Research Methodology

13. Secondary and Primary Sources

14. Assumptions and Acronyms

15. Disclaimer

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Sepsis Diagnostics Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2017 to 2026